Criminal or bystander: imatinib and second primary malignancy in GIST patients

被引：8
|
作者：
Kanda, Tatsuo [1 ]
机构：
[1] Sanjo Gen Hosp, Sanjo City, Niigata 9550055, Japan
来源：
CHINESE JOURNAL OF CANCER RESEARCH | 2013年 / 25卷 / 05期
关键词：
GASTROINTESTINAL STROMAL TUMORS; NEOPLASMS; COEXISTENCE; KIT;
D O I：
10.3978/j.issn.1000-9604.2013.10.15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：490 / 492
页数：3
相关论文
共 50 条
  • [31] Characteristics of Second Primary Lung Malignancy in Patients with Known Breast Cancer
    Kerendi, Faraz
    Gal, Anthony
    Corvera, Joel S.
    Halkos, Michael E.
    Miller, Joseph I.
    SOUTHERN MEDICAL JOURNAL, 2009, 102 (03) : 269 - 274
  • [32] Co-occurrence of second primary malignancy in patients with thyroid cancer
    Hsu, C. -H.
    Huang, C. -L.
    Hsu, Y. -H.
    Iqbal, U.
    Nguyen, P. -A.
    Jian, W. -S.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2014, 107 (08) : 643 - 648
  • [33] Risk and outcome of second primary malignancy in patients with classical Hodgkin lymphoma
    Wang, Fan
    MEDICINE, 2022, 101 (48) : E31967
  • [34] Malignant mesothelioma as a second primary malignancy
    Burgers, S.
    Tiernessen, M.
    Kegjens, J.
    Baas, P.
    LUNG CANCER, 2006, 54 : S32 - S33
  • [35] FDG-PET as a predicitve marker for primary resistance to imatinib (IM) in patients with gastrointestinal stromal tumors (GIST).
    Oosting, S.
    Den Hollander, M. W.
    Rikhof, B.
    Rouw, D. B.
    De Jong, J. R.
    Jager, P. L.
    Brouwers, A. H.
    Van der Graaf, W. T.
    De Vries, E.
    Gietema, J. A.
    Reyners, A. K. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [36] Postoperative experience in patients with metastatic GIST are similar in patients while on sunitinib or imatinib
    Raut, C.
    Morgan, J. A.
    Quigley, M. T.
    George, S.
    Wagner, A. J.
    Demetri, G.
    Bertagnolli, M. M.
    EJC SUPPLEMENTS, 2007, 5 (04): : 409 - 409
  • [37] VARYING LATENCY IMPACT ON INCIDENCE OF SECOND PRIMARY MALIGNANCY AMONG PATIENTS WITH B-CELL MALIGNANCY
    Knight, T.
    Zhou, L.
    Patel, R.
    Azmi, S.
    VALUE IN HEALTH, 2023, 26 (12) : S248 - S248
  • [38] Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy
    Kim, Hyung Jin
    Lee, Juhyeon
    Park, In-Chul
    Han, Yireh
    Seong, Min-Ki
    Noh, Woo Chul
    Kang, Hye Jin
    Kim, Hyun-Ah
    Park, Chan Sub
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2023, 105 (01) : 1 - 9
  • [39] Can Imatinib Be Safely Withdrawn in Patients with Surgically Resected Metastatic GIST?
    Hompland, Ivar
    Bruland, Oyvind S.
    ANTICANCER RESEARCH, 2015, 35 (11) : 5759 - 5765
  • [40] The role of surgical cytoreduction before imatinib therapy in patients with advanced GIST
    An, Hojung
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Sohn, Byeong Seok
    Kim, Ki-Hun
    Oh, Sung Tae
    Yu, Chang Sik
    Yook, Jeong Hwan
    Kim, Byung Sik
    Kang, Yoon-Koo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345